The role of SGLT inhibitors in managing CVD risk in Type 2 Diabetes
This free online webinar will benefit GPs, Nurse Prescribers, Practice Pharmacists and anyone involved in cardiovascular management
Learning Objectives
• Overview of the role of SGLT2i in managing cardiovascular risk and blood glucose in Type 2 Diabetes patients (including Blood Pressure improvement)
• Brief overview of the newly revised NICE guidance – Type 2 diabetes in adults
• Background and launch of the West Yorkshire Healthy Hearts Diabetes Treatment Guidance
• Approach to managing Cardiorenal Metabolic comorbidities
• Resources available to help PCNs including searches to identify suitable patients and information for patients
Speaker Panel
• Dr Waqas Tahir – West Yorkshire Health and Care Partnership Diabetes Clinical Lead
• Prof. Stephen Wheatcroft – Consultant Cardiologist – Leeds Teaching Hospitals NHS Trust / Professor of Cardiometabolic Medicine – University of Leeds
• Hannah Beba – Consultant Pharmacist (Diabetes) NHS Leeds CCG embedded in the Leeds GP Confederation
• Dr Rani Khatib – Consultant Pharmacist in Cardiology & Cardiovascular Research – Leeds Teaching Hospitals NHS Trust / National Clinical Champion for PCSK9i & Lipid Management – NHS England / Science Committee Member- European Society of Cardiology